Tower Research Capital (TRC)’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16K | Sell |
5,451
-6
| -0.1% | -$3 | ﹤0.01% | 4540 |
|
|
2025
Q1 | $3.19K | Buy |
5,457
+6
| +0.1% | +$4 | ﹤0.01% | 4454 |
|
|
2024
Q4 | $3.28K | Sell |
5,451
-30
| -0.5% | -$18 | ﹤0.01% | 4679 |
|
|
2024
Q3 | $3.78K | Buy |
5,481
+2,188
| +66% | +$1.51K | ﹤0.01% | 4774 |
|
|
2024
Q2 | $7.28K | Buy |
3,293
+2,858
| +657% | +$6.32K | ﹤0.01% | 4478 |
|
|
2024
Q1 | $1.6K | Buy |
435
+111
| +34% | +$408 | ﹤0.01% | 5236 |
|
|
2023
Q4 | $2.31K | Buy |
324
+4
| +1% | +$29 | ﹤0.01% | 5237 |
|
|
2023
Q3 | $5.03K | Hold |
320
| – | – | ﹤0.01% | 4772 |
|
|
2023
Q2 | $8.42K | Buy |
+320
| New | +$8.42K | ﹤0.01% | 4410 |
|
|
2020
Q4 | – | Sell |
-7
| Closed | -$6K | – | 5317 |
|
|
2020
Q3 | $6K | Buy |
+7
| New | +$6K | ﹤0.01% | 4298 |
|
|
2016
Q4 | – | Hold |
0
| – | -$1K | – | 4206 |
|
|
2016
Q3 | – | Hold |
0
| – | -$1K | – | 3334 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4183 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4548 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4827 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 4752 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 4457 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 4739 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 4453 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 4782 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 4773 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 4736 |
|